There are considerable risks involved, including the risk of messing up your dose or of using compounded medications, which are not FDA approved for safety, quality, or efficacy, says Zimmermann
While fatigue is not among the most common side effects reported in clinical trials, some patients experience tiredness during treatment with this dual GIP and GLP-1 receptor agonist
You can build gut health, nutrient density, and protein intake in dozens of ways
These medications activate GLP-1 receptors (and sometimes GIP receptors), helping you feel fuller for a longer period, reducing cravings, and improving metabolic function
They also identified some secondary benefits, such as lowering cholesterol
Shed received a box of semaglutide earlier in the month with a much lower dose